GET DAILY SIGNALSChicago Atlantic BDC (LIEN): A +21% Path to the $11.00 Target?
Key Takeaways
- The central target used here is $11.00, about a 21% move above a recent price near $9.05.
- This is not a multi-analyst consensus: only one widely cited published price target exists ($11 from Oppenheimer), so the objective reflects limited public coverage rather than an average of many forecasts.
- With a single target, the high and low of the available analyst range are effectively the same ($11.00), signaling thin sell-side coverage of this small-cap name.
- Supporting factors include a roughly 15% dividend yield, a 15.5% portfolio yield, zero non-accruals, and a pending merger with Chicago Atlantic Real Estate Finance.
- Key risks include a third-quarter net investment income miss, thin dividend coverage, cannabis-sector and regulatory exposure, and shares already trading well below book value.
- For more context, explore Major News, Today's Price Move, Forecast, and Earnings pages.
- Discover automated strategies and idea generation with Trending AI Robots.
Understanding the Single Analyst Target
Chicago Atlantic BDC, Inc. (LIEN) operates as a business development company focused on the cannabis ecosystem, with about 78% of its portfolio in cannabis lending and 22% in diversified direct lending. As a small-cap BDC, it receives far less sell-side attention than larger names.
Only one credible current price target stands out: $11.00 from Oppenheimer analyst Mitchel Penn, paired with a Hold rating. Aggregators such as TipRanks and MarketWatch report essentially the same $11.00 figure. In my view, this makes the target a publicly discussed objective rather than a broad consensus average.
Current Valuation and the Road to $11.00
Trading near $9.05 recently, the stock would need roughly a 21% advance to reach the target. Its net asset value stood at $13.27 per share as of September 30, 2026, so shares sit at about 0.68 times book value. Even at $11.00 the stock would remain at a discount to NAV.
Third-quarter net investment income rose to $0.36 per share from $0.34, though it missed the $0.40 consensus. The company maintained its $0.34 quarterly dividend for the ninth straight quarter. Total investment income reached $15.4 million and the portfolio expanded to a record $399.6 million.
Factors That Could Support the Target
- High income and clean credit: The weighted average gross yield on the debt portfolio is about 15.5%, with zero loans on non-accrual status, well below the broader BDC average of 3.7%.
- Dividend yield: The $1.36 annualized dividend implies a yield near 15%, which can attract income-focused investors.
- Merger scale: The planned all-stock, NAV-for-NAV merger with Chicago Atlantic Real Estate Finance should create a larger, more liquid BDC.
- Underlevered balance sheet: A 0.3x debt-to-equity ratio leaves room for additional capital deployment.
- Valuation gap: Trading at roughly 0.68x NAV, even a partial re-rating could help the stock approach $11.00.
Risks That Could Limit Upside
- Earnings miss: Third-quarter NII of $0.36 fell short of the $0.40 estimate, and dividend coverage remains thin.
- Cannabis concentration: Heavy sector exposure brings regulatory, legal, and credit risks that can affect both portfolio values and sentiment.
- Persistent discount: BDCs can trade below NAV for extended periods with no guarantee of re-rating.
- Rate sensitivity: While about 65% of the portfolio is fixed-rate or has floors, lower rates could pressure floating-rate income.
- Thin trading and coverage: Low volume and minimal analyst attention can slow price discovery.
Technical Levels Worth Watching
The 52-week range runs from roughly $8.92 to $11.27, placing the target just below the recent high. The stock has traded below its 50-day moving average near $9.56 and its 200-day moving average near $9.72. The $8.92 level offers nearby support, while $11.00–$11.27 forms a clear resistance zone.
What Investors Should Monitor Next
With only one target available, the typical 12-month horizon carries less cross-analyst insight. I’m watching quarterly NII and dividend coverage, new originations, non-accrual trends, merger progress, NAV movements, and cannabis regulatory developments. Interest-rate shifts and broader BDC sentiment also matter for this income-oriented name. I also checked comparable names using Tickeron’s AI Screener to see how LIEN stacks up within the sector.
AI Daily Buy/Sell Signals
Tickeron’s AI Daily Buy/Sell Signals apply artificial intelligence to scan thousands of stocks and ETFs, producing Buy, Sell, or Hold signals based on technical behavior and market conditions. For a thinly covered name like LIEN, these signals can help surface trend changes more efficiently than manual review alone. I find them useful as a complement when monitoring positions or screening for new ideas in the BDC space.
Final Assessment
The $11.00 objective for LIEN represents a roughly 21% move from recent levels near $9.05, though it would still leave the stock below its $13.27 NAV. Because only a single widely cited target could be verified, the figure carries less statistical weight than consensus averages for larger companies. The main supports remain the high yield, clean credit record, record portfolio size, and pending merger; the key obstacles are the recent NII miss, thin coverage, cannabis exposure, and the NAV discount. From what I see, investors should track NII trends, dividend coverage, and merger developments before drawing conclusions on whether the shares can reach $11.00.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
LIEN sees its Stochastic Oscillator climbs out of oversold territory
On November 10, 2026, the Stochastic Oscillator for LIEN moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 71 instances where the indicator left the oversold zone. In 49 of the 71 cases the stock moved higher in the following days. This puts the odds of a move higher at over 69%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where LIEN's RSI Oscillator exited the oversold zone, 11 of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 46%.
The Momentum Indicator moved above the 0 level on November 10, 2026. You may want to consider a long position or call options on LIEN as a result. In 61 of 113 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 54%.
The Moving Average Convergence Divergence (MACD) for LIEN just turned positive on October 27, 2026. Looking at past instances where LIEN's MACD turned positive, the stock continued to rise in 25 of 51 cases over the following month. The odds of a continued upward trend are 49%.
Following a +1.10% 3-day Advance, the price is estimated to grow further. Considering data from situations where LIEN advanced for three days, in 111 of 201 cases, the price rose further within the following month. The odds of a continued upward trend are 55%.
Bearish Trend Analysis
The 10-day moving average for LIEN crossed bearishly below the 50-day moving average on October 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 53%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LIEN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.
LIEN broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for LIEN entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 52 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating fairly steady price growth. LIEN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 62 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 77 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.684) is normal, around the industry mean (2.412). P/E Ratio (6.525) is within average values for comparable stocks, (-2.386). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.319). Dividend Yield (0.150) settles around the average of (0.270) among similar stocks. P/S Ratio (5.811) is also within normal values, averaging (15.694).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LIEN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry InvestmentManagers
Advertisement